Pfizer's JN.1 vaccine has been the only option available to Australians since the start of the year. Here's what happened to ...

BofA forecasts slowing overall revenue, estimating about $1 billion in 2025, slightly below the company’s guidance. It ...

Novavax, Inc. (NASDAQ:NVAX) is one of the 11 Best Short Squeeze Stocks to Buy Now. The company’s non-mRNA COVID-19 vaccine is ...

Novavax (NVAX) downgraded to Underperform by BofA due to uncertain growth outlook despite cost-cutting measures. Read more ...

Bank of America’s downgrade to ‘Underperform’ with a $7 target deepened concerns over Sanofi’s limited commercialization of ...

As previously reported, BofA downgraded Novavax (NVAX) to Underperform from Neutral with a price target of $7, down from $9, citing the recent ...

As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...

If you want a COVID-19 shot this fall, will your employer’s health insurance plan pay for it? There’s no clear answer.